The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMC 2265759)

Published in PLoS Med on March 11, 2008

Authors

Timothy B Hallett1, Simon Gregson, Sabada Dube, Geoff P Garnett

Author Affiliations

1: Department of Infectious Disease Epidemiology, Imperial College London, United Kingdom. timothy.hallett@imperial.ac.uk

Articles citing this

The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87

Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr (2011) 2.96

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies. PLoS Med (2010) 1.65

Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy. PLoS One (2011) 1.58

Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness. J Acquir Immune Defic Syndr (2010) 1.57

Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe. AIDS Behav (2009) 1.41

Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review. PLoS One (2009) 1.31

Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands. PLoS One (2008) 1.27

Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis. AIDS (2012) 1.26

Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in Mozambique. J Int AIDS Soc (2013) 1.03

Estimating the resources required in the roll-out of universal access to antiretroviral treatment in Zimbabwe. Sex Transm Infect (2011) 0.97

Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners. Sex Transm Infect (2010) 0.95

Sex role segregation and mixing among men who have sex with men: implications for biomedical HIV prevention interventions. PLoS One (2013) 0.80

T-cell enumeration from dried blood spots by quantifying rearranged T-cell receptor-beta genes. J Immunol Methods (2010) 0.77

Factors affecting timing of antiretroviral treatment initiation based on monitoring CD4 counts. J Acquir Immune Defic Syndr (2012) 0.75

Articles cited by this

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet (2006) 31.79

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet (2006) 11.06

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA (2000) 10.17

HIV decline associated with behavior change in eastern Zimbabwe. Science (2006) 6.98

Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med (2006) 4.86

HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS (2002) 4.56

Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the Spectrum projection package. Sex Transm Infect (2006) 4.13

Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. Nat Med (1995) 3.46

AIDS--the first 20 years. N Engl J Med (2001) 3.26

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antivir Ther (2006) 2.85

Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr (1990) 2.84

National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines? AIDS (2006) 2.82

The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science (2006) 2.76

When to initiate antiretroviral therapy in HIV-1-infected adults: a review for clinicians and patients. Lancet Infect Dis (2005) 2.48

Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. BMJ (2002) 2.31

Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ (2006) 2.20

Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.68

HIV-1 disease progression and fertility: the incidence of recognized pregnancy and pregnancy outcome in Uganda. AIDS (2004) 1.63

When to start therapy for HIV infection: a swinging pendulum in search of data. Ann Intern Med (2003) 1.63

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005). HIV Med (2005) 1.60

Assessing adult mortality in HIV-1-afflicted Zimbabwe (1998 -2003). Bull World Health Organ (2006) 1.42

The contribution of HIV to fertility decline in rural Zimbabwe, 1985-2000. Popul Stud (Camb) (2003) 1.31

Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers. AIDS (1999) 1.31

Supply and demand: estimating the real need for care while meeting the 48 hour waiting time target in a genitourinary medicine clinic by a closed appointment system. Sex Transm Infect (2006) 1.26

No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study. J Infect Dis (2002) 1.22

Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults. Arch Intern Med (2002) 1.21

Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe. Clin Vaccine Immunol (2007) 1.17

The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: mechanisms and clinical implications. Proc Biol Sci (2001) 1.14

Comparison of two alternative methods for CD4+ T-cell determination (Coulter manual CD4 count and CyFlow) against standard dual platform flow cytometry in Uganda. Cytometry B Clin Cytom (2006) 0.98

Is there a general tendency for CD4 lymphocyte decline to speed up during human immunodeficiency virus infection? Evidence from the Italian Seroconversion Study. J Infect Dis (1997) 0.97

Bayes estimates for immunological progression rates in HIV disease. Stat Med (1997) 0.92

Distribution of CD4+ T-lymphocytes levels in patients with clinical symptoms of AIDS in three west African countries. J Clin Virol (1998) 0.88

Early manifestations (pre-AIDS) of HIV-1 infection in Uganda. AIDS (1998) 0.86

Retracted Validity of existing CD4+ classification in north Indians, in predicting immune status. J Infect (2005) 0.85

The natural course of disease following HIV-1 infection in dar es salaam, Tanzania: a study among hotel workers relating clinical events to CD4 T-lymphocyte counts. Scand J Infect Dis (2004) 0.80

Articles by these authors

Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet (2002) 5.21

Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS (2003) 4.87

Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet (2004) 4.13

Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS (2010) 4.05

Voluntary counselling and testing: uptake, impact on sexual behaviour, and HIV incidence in a rural Zimbabwean cohort. AIDS (2007) 3.54

Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One (2008) 3.32

Understanding the uneven spread of HIV within Africa: comparative study of biologic, behavioral, and contextual factors in rural populations in Tanzania and Zimbabwe. Sex Transm Dis (2003) 3.13

Effects of unconditional and conditional cash transfers on child health and development in Zimbabwe: a cluster-randomised trial. Lancet (2013) 2.98

HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review. Int J Epidemiol (2010) 2.96

The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science (2006) 2.76

Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med (2011) 2.76

Scale-free networks and sexually transmitted diseases: a description of observed patterns of sexual contacts in Britain and Zimbabwe. Sex Transm Dis (2004) 2.75

Creating and validating an algorithm to measure AIDS mortality in the adult population using verbal autopsy. PLoS Med (2006) 2.70

Extended family's and women's roles in safeguarding orphans' education in AIDS-afflicted rural Zimbabwe. Soc Sci Med (2004) 2.68

Modelling the impact of migration on the HIV epidemic in South Africa. AIDS (2007) 2.63

Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med (2006) 2.52

The theoretical population-level impact of a prophylactic human papilloma virus vaccine. Epidemiology (2002) 2.49

Estimating incidence from prevalence in generalised HIV epidemics: methods and validation. PLoS Med (2008) 2.42

The population impact of HIV on fertility in sub-Saharan Africa. AIDS (2004) 2.32

Masculinity as a barrier to men's use of HIV services in Zimbabwe. Global Health (2011) 2.27

A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med (2011) 2.23

Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic? Lancet (2004) 2.20

Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ (2006) 2.20

HIV incidence and poverty in Manicaland, Zimbabwe: is HIV becoming a disease of the poor? AIDS (2007) 2.13

Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med (2006) 2.10

Quantifying sexual exposure to HIV within an HIV-serodiscordant relationship: development of an algorithm. AIDS (2011) 2.10

Updates to the spectrum model to estimate key HIV indicators for adults and children. AIDS (2014) 2.09

From affected to infected? Orphanhood and HIV risk among female adolescents in urban Zimbabwe. AIDS (2008) 2.06

Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to data from Zimbabwe. Epidemics (2009) 2.05

Prevalences of sexually transmitted infections in young adults and female sex workers in Peru: a national population-based survey. Lancet Infect Dis (2012) 2.03

HIV-associated orphanhood and children's psychosocial distress: theoretical framework tested with data from Zimbabwe. Am J Public Health (2007) 2.03

Back to basics in HIV prevention: focus on exposure. BMJ (2003) 1.99

The forgotten half of the equation: randomized controlled trial of a male invitation to attend couple voluntary counselling and testing. AIDS (2011) 1.99

Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial. Lancet (2012) 1.80

The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg Themes Epidemiol (2005) 1.76

Social capital and HIV competent communities: the role of community groups in managing HIV/AIDS in rural Zimbabwe. AIDS Care (2013) 1.73

Beer halls as a focus for HIV prevention activities in rural Zimbabwe. Sex Transm Dis (2005) 1.72

Vicious and virtuous circles in the dynamics of infectious disease and the provision of health care: gonorrhea in Britain as an example. J Infect Dis (2005) 1.71

Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age. PLoS One (2009) 1.62

Patterns of movement and risk of HIV infection in rural Zimbabwe. J Infect Dis (2005) 1.62

Exploring children's stigmatisation of AIDS-affected children in Zimbabwe through drawings and stories. Soc Sci Med (2010) 1.61

No difference in HIV incidence and sexual behaviour between out-migrants and residents in rural Manicaland, Zimbabwe. Trop Med Int Health (2006) 1.60

Estimates of HIV incidence from household-based prevalence surveys. AIDS (2010) 1.59

InterVA-4 as a public health tool for measuring HIV/AIDS mortality: a validation study from five African countries. Glob Health Action (2013) 1.59

Rising incidence and prevalence of orphanhood in Manicaland, Zimbabwe, 1998 to 2003. AIDS (2005) 1.56

Clandestine induced abortion: prevalence, incidence and risk factors among women in a Latin American country. CMAJ (2009) 1.55

HIV incidence in 3 years of follow-up of a Zimbabwe cohort--1998-2000 to 2001-03: contributions of proximate and underlying determinants to transmission. Int J Epidemiol (2008) 1.54

Age at first sex and HIV infection in rural Zimbabwe. Stud Fam Plann (2007) 1.53

"We, the AIDS people. . .": how antiretroviral therapy enables Zimbabweans living with HIV/AIDS to cope with stigma. Am J Public Health (2010) 1.51

Is education the link between orphanhood and HIV/HSV-2 risk among female adolescents in urban Zimbabwe? Soc Sci Med (2009) 1.50

When masculinity interferes with women's treatment of HIV infection: a qualitative study about adherence to antiretroviral therapy in Zimbabwe. J Int AIDS Soc (2011) 1.49

Obstacles to local-level AIDS competence in rural Zimbabwe: putting HIV prevention in context. AIDS Care (2010) 1.46

Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom. Vaccine (2009) 1.45

Assessing adult mortality in HIV-1-afflicted Zimbabwe (1998 -2003). Bull World Health Organ (2006) 1.42

Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe. AIDS Behav (2009) 1.41

Strong association between in-migration and HIV prevalence in urban sub-Saharan Africa. Sex Transm Dis (2010) 1.37

Contextual and psychosocial influences on antiretroviral therapy adherence in rural Zimbabwe: towards a systematic framework for programme planners. Int J Health Plann Manage (2011) 1.37

The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study. PLoS Med (2012) 1.35

Building adherence-competent communities: factors promoting children's adherence to anti-retroviral HIV/AIDS treatment in rural Zimbabwe. Health Place (2011) 1.32

Using age-specific mortality of HIV infected persons to predict anti-retroviral treatment need: a comparative analysis of data from five African population-based cohort studies. Trop Med Int Health (2012) 1.32

Changing patterns of adult mortality as the HIV epidemic matures in Manicaland, eastern Zimbabwe. AIDS (2007) 1.31

The contribution of HIV to fertility decline in rural Zimbabwe, 1985-2000. Popul Stud (Camb) (2003) 1.31

Family planning and HIV: strange bedfellows no longer. AIDS (2009) 1.28

Individual level injection history: a lack of association with HIV incidence in rural Zimbabwe. PLoS Med (2005) 1.28

Appropriate evaluation of HIV prevention interventions: from experiment to full-scale implementation. Sex Transm Infect (2007) 1.26

A 'good hospital': nurse and patient perceptions of good clinical care for HIV-positive people on antiretroviral treatment in rural Zimbabwe--a mixed-methods qualitative study. Int J Nurs Stud (2010) 1.22

The role of community conversations in facilitating local HIV competence: case study from rural Zimbabwe. BMC Public Health (2013) 1.22

Who is getting Pap smears in urban Peru? Int J Epidemiol (2008) 1.19

Measuring and correcting biased child mortality statistics in countries with generalized epidemics of HIV infection. Bull World Health Organ (2010) 1.17

Poorer health and nutritional outcomes in orphans and vulnerable young children not explained by greater exposure to extreme poverty in Zimbabwe. Trop Med Int Health (2007) 1.16

Local perceptions of the forms, timing and causes of behavior change in response to the AIDS epidemic in Zimbabwe. AIDS Behav (2011) 1.16

Patterns of uptake of HIV testing in sub-Saharan Africa in the pre-treatment era. Trop Med Int Health (2012) 1.10

Household-based cash transfer targeting strategies in Zimbabwe: are we reaching the most vulnerable children? Soc Sci Med (2012) 1.08

Children's representations of school support for HIV-affected peers in rural Zimbabwe. BMC Public Health (2014) 1.07

When did HIV incidence peak in Harare, Zimbabwe? Back-calculation from mortality statistics. PLoS One (2008) 1.07

Mortality trends in the era of antiretroviral therapy: evidence from the Network for Analysing Longitudinal Population based HIV/AIDS data on Africa (ALPHA). AIDS (2014) 1.06

Estimating vertically acquired HIV infections and the impact of the prevention of mother-to-child transmission program in Zimbabwe: insights from decision analysis models. J Acquir Immune Defic Syndr (2008) 1.02

Transmission dynamics of the four dengue serotypes in southern Vietnam and the potential impact of vaccination. PLoS One (2012) 1.00

Evaluating the proximate determinants framework for HIV infection in rural Zimbabwe. Sex Transm Infect (2007) 1.00

Social acceptability and perceived impact of a community-led cash transfer programme in Zimbabwe. BMC Public Health (2013) 0.97

The impact of HIV on children's education in eastern Zimbabwe. AIDS Care (2014) 0.97

Reaching the unreachable: providing STI control services to female sex workers via mobile team outreach. PLoS One (2013) 0.97

Is HIV out of control in the UK? An example of analysing patterns of HIV spreading using incidence-to-prevalence ratios. AIDS (2006) 0.97

Increasing adolescent HIV prevalence in Eastern Zimbabwe--evidence of long-term survivors of mother-to-child transmission? PLoS One (2013) 0.96

Development and future directions for the Joint United Nations Programme on HIV/AIDS estimates. AIDS (2014) 0.96

Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners. Sex Transm Infect (2010) 0.95

Seroepidemiology of Trichomonas vaginalis in rural women in Zimbabwe and patterns of association with HIV infection. Epidemiol Infect (2005) 0.93

HPV-16 infection and cervical cancer: modeling the influence of duration of infection and precancerous lesions. Epidemics (2010) 0.93

Population-level risk factors for HIV transmission and 'the 4 Cities Study': temporal dynamics and the significance of sexual mixing patterns. AIDS (2002) 0.91

The role of sexually transmitted infections in male circumcision effectiveness against HIV--insights from clinical trial simulation. Emerg Themes Epidemiol (2006) 0.90

Embracing different approaches to estimating HIV incidence, prevalence and mortality. AIDS (2014) 0.88

Monitoring trends in HIV prevalence among young people, aged 15 to 24 years, in Manicaland, Zimbabwe. J Int AIDS Soc (2011) 0.88